Christopher C. Caillouet

Array ( [id] => 990826 [patent_doc_number] => 06919353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-19 [patent_title] => 'Substituted 8-arylquinolune PDE4 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/478791 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42247 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/919/06919353.pdf [firstpage_image] =>[orig_patent_app_number] => 10478791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651426 [patent_doc_number] => 20030105065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Novel quinolines and uses thereof' [patent_app_type] => new [patent_app_number] => 10/177990 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37788 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105065.pdf [firstpage_image] =>[orig_patent_app_number] => 10177990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800420 [patent_doc_number] => 07425564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same' [patent_app_type] => utility [patent_app_number] => 10/480632 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42737 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425564.pdf [firstpage_image] =>[orig_patent_app_number] => 10480632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209685 [patent_doc_number] => 06713462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Quinolinones and uses thereof' [patent_app_type] => B2 [patent_app_number] => 10/177500 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47619 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713462.pdf [firstpage_image] =>[orig_patent_app_number] => 10177500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053297 [patent_doc_number] => 06858626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Cyclic hydroxamic acid as metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/177235 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42506 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858626.pdf [firstpage_image] =>[orig_patent_app_number] => 10177235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278702 [patent_doc_number] => 06645957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-11 [patent_title] => 'Cyclic amide compound' [patent_app_type] => B2 [patent_app_number] => 10/173670 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17271 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645957.pdf [firstpage_image] =>[orig_patent_app_number] => 10173670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113325 [patent_doc_number] => 20020173657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Method for the synthesis of quinoline derivatives' [patent_app_type] => new [patent_app_number] => 10/174458 [patent_app_country] => US [patent_app_date] => 2002-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9568 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173657.pdf [firstpage_image] =>[orig_patent_app_number] => 10174458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276430 [patent_doc_number] => 20040235881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Immune response modifiers for the treatment of periodontal disease' [patent_app_type] => new [patent_app_number] => 10/479109 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10454 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235881.pdf [firstpage_image] =>[orig_patent_app_number] => 10479109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178084 [patent_doc_number] => 20020156097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Salts of quinoline derivatives as NK3 antagonists' [patent_app_type] => new [patent_app_number] => 10/167881 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6560 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156097.pdf [firstpage_image] =>[orig_patent_app_number] => 10167881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856667 [patent_doc_number] => 20030130168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Reverse-turn mimetics and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/167979 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8747 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130168.pdf [firstpage_image] =>[orig_patent_app_number] => 10167979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335119 [patent_doc_number] => 06596879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Process for the synthesis of 1,3-diols' [patent_app_type] => B2 [patent_app_number] => 10/166990 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4863 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596879.pdf [firstpage_image] =>[orig_patent_app_number] => 10166990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733525 [patent_doc_number] => 07038054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Diazabicyclononane scaffold for combinatorial synthesis' [patent_app_type] => utility [patent_app_number] => 10/166833 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4711 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/038/07038054.pdf [firstpage_image] =>[orig_patent_app_number] => 10166833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805452 [patent_doc_number] => 20030232846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Caspase inhibitors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/166437 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19243 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232846.pdf [firstpage_image] =>[orig_patent_app_number] => 10166437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261738 [patent_doc_number] => 06664249 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Bicyclic vasopressin agonists' [patent_app_type] => B1 [patent_app_number] => 10/111007 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7353 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664249.pdf [firstpage_image] =>[orig_patent_app_number] => 10111007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236085 [patent_doc_number] => 06689799 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => '1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof' [patent_app_type] => B1 [patent_app_number] => 10/069216 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4711 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689799.pdf [firstpage_image] =>[orig_patent_app_number] => 10069216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303756 [patent_doc_number] => 06620825 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Adenosine A3 receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 10/161181 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25813 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620825.pdf [firstpage_image] =>[orig_patent_app_number] => 10161181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1102022 [patent_doc_number] => 06815465 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-09 [patent_title] => 'Heterocyclic compounds inhibiting angiogenesis' [patent_app_type] => B1 [patent_app_number] => 10/048659 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10163 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815465.pdf [firstpage_image] =>[orig_patent_app_number] => 10048659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774604 [patent_doc_number] => 20030017942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Chiral catalysts for asymmetric acylation and related transformations' [patent_app_type] => new [patent_app_number] => 10/130292 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8554 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017942.pdf [firstpage_image] =>[orig_patent_app_number] => 10130292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448167 [patent_doc_number] => 20040186133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands' [patent_app_type] => new [patent_app_number] => 10/478721 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7604 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186133.pdf [firstpage_image] =>[orig_patent_app_number] => 10478721 [rel_patent_id] =>[rel_patent_doc_number] =>)